, the Hong-Kong based group focused on the installation and maintenance of surveillance systems and security products, announced on Wednesday that it had appointed a major subcontractor.
The group said that China Railway Engineering Limited (‘CREHK’) will be working with the group to deliver any existing contractual obligations.
This will also include China Railway Wuhan Electrification Engineering Group Limited (‘CRWE’) -- the two groups will be working together in a CREHK-CRWE Joint Venture.
CRWE is subsidiary of China Railway Group, one of the largest construction companies in the world, listed in both Shanghai and Hong Kong and holding employees of more than 250,000.
In particular, CRWE will be able to provide “significant manpower, finance and other resources,” the firm explained, in order to help meet the contractual obligations in a more efficient and cost-effective manner.
“We believe this strategic partnership will bring significant advantages to UniVision in that we can utilise CRWE's sourcing capability and financial strength with both current and other potential customers,” said Stephen Koo, Chairman of UniVision.
The group consider the CREHK-CRWE Joint Venture to offer a more positive impact on UniVision's contractual Gross Margins than the wide range of smaller sub-contractors currently being used.
“Whilst this is the first time we have worked with CRG, we are aware that, as one of the world's largest construction and engineering companies, other opportunities may present themselves in the future,” Mr Koo added.
Follow News & Updates from UniVision here:
Disclaimer & Declaration of Interest
The information, investment views and recommendations in this article are provided for general information purposes only. Nothing in this article should be construed as a solicitation to buy or sell any financial product relating to any companies under discussion or to engage in or refrain from doing so or engaging in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the writer but no responsibility is accepted for actions based on such opinions or comments. Vox Markets may receive payment from companies mentioned for enhanced profiling or publication presence. The writer may or may not hold investments in the companies under discussion.
- Xpediator, Cora Gold & Hummingbird Resources plus Russ Mould on Saudi Aramco & OPEC
6th Dec 2019Xpediator discuss the highs and lows from 2019 and what's to come in 2020. Cora Gold discuss their maiden resource at Sanankoro and also provides an update on Hummingbird Resources. Russ Mould talks about the Saudi Aramco IPO & OPEC's latest meeting.
- Armadale Capital officially appoints Ged Hall as Non-Executive Director
Francesca MorganCompany News - 2 mins6th Dec 2019“We are delighted to welcome Ged Hall to the Board at such an exciting time as we look to progress the Mahenge Liandu graphite project from exploration to production,” said Johansen.
- ReNeuron Group sees "significant progress" across clinical and research programmes
Francesca MorganCompany News - 2 mins6th Dec 2019ReNeuron said it was in ongoing discussions with other commercial third parties for potential out-licence deals and Chief Executive, Olav Hellebø, says he expects to announce further deals “in the months ahead.”
- Morning Financial Press Review 06/12/19
6th Dec 2019Lawrence Stroll, the billionaire owner of the Racing Point Formula One motor racing team, is said to be preparing to bid for a significant stake in Aston Martin, BP has increased its stake in the British solar venture Lightsource BP as it prepares to strike a deal to power its offices with renewable energy from next year
- EVR Holding's Melody VR platform extends O2 partnership
Francesca MorganCompany News - 2 mins5th Dec 2019O2 announced the launch of O2 extras this morning to offer flexibility and affordability for its customers -- the programme will be on offer to new and upgrading pay monthly customers on a handset, tablet or SIM only contracts.
- Q&A with Nuformix (NFX) CEO Dr. Dan Gooding
5th Dec 2019Nuformix (NFX) Chief Executive Officer Dr. Dan Gooding discusses some of the speculation surrounding the leaked article in the press, answers questions investors had regarding upcoming licensing deals, and discusses a potential exit strategy for the company.
